Search Results

There are 10641 results for: content related to: Developing limits for driving under cannabis

  1. Cannabis use: a perspective in relation to the proposed UK drug-driving legislation

    Drug Testing and Analysis

    Volume 6, Issue 1-2, January-February 2014, Pages: 143–154, Kim Wolff and Atholl Johnston

    Version of Record online : 11 DEC 2013, DOI: 10.1002/dta.1588

  2. You have free access to this content
    Current knowledge on cannabinoids in oral fluid

    Drug Testing and Analysis

    Volume 6, Issue 1-2, January-February 2014, Pages: 88–111, Dayong Lee and Marilyn A. Huestis

    Version of Record online : 25 AUG 2013, DOI: 10.1002/dta.1514

  3. You have free access to this content
    The effects of Δ9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide

    British Journal of Pharmacology

    Volume 145, Issue 4, June 2005, Pages: 514–526, Saoirse E O'Sullivan, David A Kendall and Michael D Randall

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706218

  4. Evaluation of a vaporizing device (Volcano®) for the pulmonary administration of tetrahydrocannabinol

    Journal of Pharmaceutical Sciences

    Volume 95, Issue 6, June 2006, Pages: 1308–1317, Arno Hazekamp, Renee Ruhaak, Lineke Zuurman, Joop van Gerven and Rob Verpoorte

    Version of Record online : 24 APR 2006, DOI: 10.1002/jps.20574

  5. You have free access to this content
    The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

    British Journal of Pharmacology

    Volume 153, Issue 2, January 2008, Pages: 199–215, R G Pertwee

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0707442

  6. You have free access to this content
    Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway

    The EMBO Journal

    Volume 33, Issue 7, 1 April 2014, Pages: 668–685, Giuseppe Tortoriello, Claudia V Morris, Alan Alpar, Janos Fuzik, Sally L Shirran, Daniela Calvigioni, Erik Keimpema, Catherine H Botting, Kirstin Reinecke, Thomas Herdegen, Michael Courtney, Yasmin L Hurd and Tibor Harkany

    Version of Record online : 27 JAN 2014, DOI: 10.1002/embj.201386035

  7. Simultaneous determination of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy- Δ9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry

    Journal of Mass Spectrometry

    Volume 39, Issue 5, May 2004, Pages: 526–531, Barbora Maralikova and Wolfgang Weinmann

    Version of Record online : 11 MAR 2004, DOI: 10.1002/jms.616

  8. You have free access to this content
    Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties

    European Journal of Immunology

    Volume 40, Issue 12, December 2010, Pages: 3358–3371, Venkatesh L. Hegde, Mitzi Nagarkatti and Prakash S. Nagarkatti

    Version of Record online : 25 NOV 2010, DOI: 10.1002/eji.201040667

  9. You have free access to this content
    Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ9-tetrahydrocannabinol in Sprague-Dawley rats

    British Journal of Pharmacology

    Volume 172, Issue 7, April 2015, Pages: 1783–1791, Michael A Taffe, Kevin M Creehan and Sophia A Vandewater

    Version of Record online : 23 JAN 2015, DOI: 10.1111/bph.13024

  10. Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans

    Journal of Pharmaceutical Sciences

    Volume 93, Issue 5, May 2004, Pages: 1176–1184, Myrtha Naef, Stefan Russmann, Steen Petersen-Felix and Rudolf Brenneisen

    Version of Record online : 23 FEB 2004, DOI: 10.1002/jps.20037

  11. You have free access to this content
    Tetrahydrocannabinol-induced neurotoxicity depends on CB1 receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons

    British Journal of Pharmacology

    Volume 140, Issue 3, October 2003, Pages: 547–557, Eric J Downer, Marie P Fogarty and Veronica A Campbell

    Version of Record online : 2 FEB 2009, DOI: 10.1038/sj.bjp.0705464

  12. A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray

    Clinical Pharmacology in Drug Development

    Volume 2, Issue 3, July 2013, Pages: 285–294, Edward M. Sellers, Kerri Schoedel, Cindy Bartlett, Myroslava Romach, Ethan B. Russo, Colin G. Stott, Stephen Wright, Linda White, Paul Duncombe and Chien-Feng Chen

    Version of Record online : 14 MAY 2013, DOI: 10.1002/cpdd.36

  13. You have free access to this content
    Δ9-Tetrahydrocannabinol inhibits electrically-evoked CGRP release and capsaicin-sensitive sensory neurogenic vasodilatation in the rat mesenteric arterial bed

    British Journal of Pharmacology

    Volume 152, Issue 5, November 2007, Pages: 709–716, J D Wilkinson, D A Kendall and V Ralevic

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0707448

  14. You have free access to this content
    Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

    British Journal of Pharmacology

    Volume 172, Issue 3, February 2015, Pages: 737–753, John M McPartland, Marnie Duncan, Vincenzo Di Marzo and Roger G Pertwee

    Version of Record online : 8 JAN 2015, DOI: 10.1111/bph.12944

  15. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …

    Headache: The Journal of Head and Face Pain

    Volume 55, Issue 6, June 2015, Pages: 885–916, Eric P. Baron

    Version of Record online : 25 MAY 2015, DOI: 10.1111/head.12570

  16. You have free access to this content
    The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys

    British Journal of Pharmacology

    Volume 164, Issue 2b, September 2011, Pages: 655–666, Jennifer L Stewart and Lance R McMahon

    Version of Record online : 28 AUG 2011, DOI: 10.1111/j.1476-5381.2011.01388.x

  17. You have free access to this content
    Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Δ-9-tetrahydrocannabinol

    British Journal of Pharmacology

    Volume 125, Issue 7, December 1998, Pages: 1567–1577, Daniel M Hutcheson, Eleni Th. Tzavara, Claire Smadja, Emmanuel Valjent, Bernard P Roques, Jacques Hanoune and Rafael Maldonado

    Version of Record online : 17 FEB 2009, DOI: 10.1038/sj.bjp.0702228

  18. You have free access to this content
    Behavioural and biochemical evidence for interactions between Δ9-tetrahydrocannabinol and nicotine

    British Journal of Pharmacology

    Volume 135, Issue 2, January 2002, Pages: 564–578, Emmanuel Valjent, Jennifer M Mitchell, Marie-Jo Besson, Jocelyne Caboche and Rafael Maldonado

    Version of Record online : 2 FEB 2009, DOI: 10.1038/sj.bjp.0704479

  19. You have free access to this content
    Chronic Δ9-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids

    British Journal of Pharmacology

    Volume 162, Issue 5, March 2011, Pages: 1060–1073, Lance R. McMahon

    Version of Record online : 28 JAN 2011, DOI: 10.1111/j.1476-5381.2010.01116.x

  20. Cannabis sativa and the Endogenous Cannabinoid System: Therapeutic Potential for Appetite Regulation

    Phytotherapy Research

    Volume 25, Issue 2, February 2011, Pages: 170–188, Jonathan A. Farrimond, Marion S. Mercier, Benjamin J. Whalley and Claire M. Williams

    Version of Record online : 7 JAN 2011, DOI: 10.1002/ptr.3375